PACS group co-founder, CEO & chairman Jason Murray sells $2.9M in shares

Jason Hulse Murray, the co-founder, CEO, and chairman of PACS Group, Inc. (NASDAQ: PACS), divested 68,113 shares of the company's common stock, garnering a total of $2,903,752 between September 1 and September 3, 2026. The sales were carried out pursuant to a pre-established Rule 10b5-1 trading plan, issued on May 18, 2026. The shares were systematically sold in various transactions, with prices fluctuating between $42.3519 and $43.3639 per share.

As of the present, PACS Group's stock is trading at $43.07, indicating a substantial 284% increase over the past year. Following these sales, Mr. Murray remains a substantial shareholder, owning 54,626,753 shares directly. InvestingPro's evaluation suggests that PACS Group is slightly undervalued at current market levels, boasting a robust financial health score.

For those interested in a deeper analysis, 11 ProTips and a comprehensive Pro Research Report are available on the InvestingPro platform. Apart from his roles as CEO and chairman, Mr. Murray also serves as a Director and 10% Owner of the company. In other recent developments, PACS Group has strategically expanded its footprint in the healthcare sector.

The company has announced the acquisition of 32 skilled nursing facilities in Florida, adding 4,049 skilled nursing beds to its portfolio. This acquisition is part of a larger agreement with Omega Healthcare Investors, Inc., and is anticipated to be finalized in the fourth quarter. Furthermore, PACS Group has sealed agreements to acquire 34 skilled nursing facilities from Eduro Healthcare, broadening its presence across six western states, including Texas, Montana, and South Dakota, adding 3,633 skilled nursing beds to its existing portfolio.

Truist Securities has maintained a Buy rating on PACS Group, setting a price target of $62.00 following the Florida acquisition news. These strategic moves are viewed as significant expansions for the company by market analysts. Additionally, PACS Group's options trading has experienced a notable surge, with a considerable number of call options being actively traded.

These recent acquisitions and trading activities underscore PACS Group's relentless pursuit of growth and expansion in the healthcare industry. This report has been AI-assisted and thoroughly reviewed by an editor.